Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH
- PMID: 8046351
- PMCID: PMC2191616
- DOI: 10.1084/jem.180.2.751
Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH
Abstract
The predominant peptides bound to major histocompatibility complex class II molecules expressed on human B cells are derived from a relatively limited number of self proteins. To determine whether any of the prebound self peptides might be released in endosomes during recycling, water-soluble HLA-DR1 molecules were incubated with a high affinity synthetic peptide at pH 4.0 and 7.0 at 37 degrees C. The resulting bound peptide repertoire was then acid extracted, and separated by reversed-phase high performance liquid chromatography. Using a combination of mass spectrometry and ultraviolet spectroscopy, prebound self peptides and newly bound synthetic peptide were characterized. Most self peptides bound to HLA-DR1 were not appreciably released during extended exposure to pH 4.0. However, some invariant chain-derived peptides were uniquely released at this pH.
Similar articles
-
Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.Arzneimittelforschung. 1999 Sep;49(9):791-9. Arzneimittelforschung. 1999. PMID: 10514908
-
Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.Nature. 1992 Aug 27;358(6389):764-8. doi: 10.1038/358764a0. Nature. 1992. PMID: 1380674
-
Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1.Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11289-93. doi: 10.1073/pnas.92.24.11289. Proc Natl Acad Sci U S A. 1995. PMID: 7479981 Free PMC article.
-
The MHC class II-associated invariant chain-derived peptide clip binds to the peptide-binding groove of class II molecules.Mol Immunol. 1996 Mar-Apr;33(4-5):371-7. doi: 10.1016/0161-5890(95)00159-x. Mol Immunol. 1996. PMID: 8676888
-
Another twist to MHC-peptide recognition.Science. 1996 May 17;272(5264):973-4. doi: 10.1126/science.272.5264.973. Science. 1996. PMID: 8638141 Review. No abstract available.
Cited by
-
Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.J Exp Med. 1995 Feb 1;181(2):527-36. doi: 10.1084/jem.181.2.527. J Exp Med. 1995. PMID: 7836909 Free PMC article.
-
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?Br J Cancer. 2000 Nov;83(9):1192-201. doi: 10.1054/bjoc.2000.1415. Br J Cancer. 2000. PMID: 11027433 Free PMC article.
-
Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9724-9. doi: 10.1073/pnas.93.18.9724. Proc Natl Acad Sci U S A. 1996. PMID: 8790398 Free PMC article.
-
Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.J Exp Med. 1996 Nov 1;184(5):2019-24. doi: 10.1084/jem.184.5.2019. J Exp Med. 1996. PMID: 8920889 Free PMC article.
-
A structural transition in class II major histocompatibility complex proteins at mildly acidic pH.J Exp Med. 1996 Jan 1;183(1):127-36. doi: 10.1084/jem.183.1.127. J Exp Med. 1996. PMID: 8551215 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
